| Literature DB >> 35863343 |
Maryam Bonakdar1, Lindsay C Czuba2, Geongoo Han1, Guo Zhong2, Hien Luong1, Nina Isoherrannen3, Shipra Vaishnava4.
Abstract
Conversion of dietary vitamin A (VA) into retinoic acid (RA) is essential for many biological processes and thus far studied largely in mammalian cells. Using targeted metabolomics, we found that commensal bacteria in the mouse gut lumen produced a high concentration of the active retinoids, all-trans-retinoic acid (atRA) and 13-cis-retinoic acid (13cisRA), as well as the principal circulating retinoid, retinol. Ablation of anerobic bacteria significantly reduced retinol, atRA, and 13cisRA, whereas introducing these bacteria into germ-free mice significantly enhanced retinoids. Remarkably, cecal bacterial supplemented with VA produced active retinoids in vitro, establishing that gut bacteria encode metabolic machinery necessary for multistep conversion of dietary VA into its active forms. Finally, gut bacteria Lactobacillus intestinalis metabolized VA and specifically restored RA levels in the gut of vancomycin-treated mice. Our work establishes vitamin A metabolism as an emergent property of the gut microbiome and lays the groundwork for developing probiotic-based retinoid therapy.Entities:
Keywords: 13-cis-retinoic acid; LC-MS/MS; all-trans-retinoic acid; germ-free mice; microbiome; retinol; vitamin A metabolism
Mesh:
Substances:
Year: 2022 PMID: 35863343 PMCID: PMC9378501 DOI: 10.1016/j.chom.2022.06.011
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 31.316